Skip to main content

Table 1 Baseline characteristics of the study population

From: Non-insulin-based insulin resistance indexes in predicting severity for coronary artery disease

 

Total (n = 485)

Single-vessel CAD (n = 116)

Multi-vessel CAD (n = 369)

P-value

Age (years)

60 (52, 67)

57 (52, 65)

61 (52.50, 67)

0.028

Male (n, %)

359 (74%)

86 (74.10%)

273 (74%)

0.974

BMI (kg/m2)

25.69 (23.53, 27.98)

25.24 (22.52, 26.82)

25.95 (23.88. 28.33)

 < 0.001

DM (n, %)

185 (38.10%)

21 (18.10%)

164 (44.40%)

 < 0.001

Smoking (n, %)

200 (41.20%)

56 (48.30%)

144 (39%)

0.077

Drinking (n, %)

67 (13.80%)

18 (15.50%)

49 (13.30%)

0.542

Hypertension (n, %)

225 (46.40%)

41 (35.30%)

184 (49.90%)

0.006

HbA1c (%)

6.10 (5.70, 7)

5.80 (5.50, 6.30)

6.20 (5.70, 7.40)

 < 0.001

FPG (mmol/l)

7.47 (6.21, 10.14)

6.89 (5.99, 8.10)

7.68 (6.29, 10.68)

 < 0.001

TC (mmol/l)

4.76 (3.98, 5.60)

4.76 (4.30, 5.49)

4.77 (3.94, 5.65)

0.684

TG (mmol/l)

1.31 (0.94, 1.81)

1.15 (0.82, 1.53)

1.38 (0.97, 1.89)

 < 0.001

HDL-C (mmol/l)

1.12 (0.93, 1.29)

1.23 (1.06, 1.36)

1.08 (0.91, 1.26)

 < 0.001

LDL-C (mmol/l)

3.20 (2.48, 3.86)

3.24 (2.66, 3.77)

3.18 (2.41, 3.91)

0.636

UA (umol/l)

368.90 (306.15, 448.95)

353.60 (301.45, 419.53)

376.70 (307.25, 458)

0.053

LAD (mm)

35.60 (32.50, 38.30)

34.20 (31.60, 36.50)

35.80 (32.90, 38.70)

0.001

LVDd (mm)

46.60 (43.60, 49.70)

46.60 (43.30, 48.80)

46.60 (43.80, 50.13)

0.156

LVDs (mm)

29.60 (25.60, 33.55)

29.40 (25, 32.80)

29.60 (25.90, 33.90)

0.271

IVS (mm)

10.80 (10.10, 11.60)

10.60 (9.90, 11.30)

10.90 (10.10, 11.80)

0.010

LVPW (mm)

10.50 (10, 11.20)

10.30 (10, 10.80)

10.50 (10, 11.23)

0.020

LVEF (%)

59 (52.45, 62)

58.80 (54.10, 62)

59.10 (52, 62)

0.706

BNP (pg/ml)

551 (165.50, 1514)

327.50 (137.50, 928)

702 (190.50, 1726.50)

0.001

D-dimer (ug/ml)

94 (52.50, 175)

86.50 (48, 188.25)

96 (56.50, 172.50)

0.319

CRP (mg/l)

6.14 (2.02, 13.20)

5.53 (1.63, 12.94)

6.36 (2.25, 13.23)

0.368

Cr (umol/l)

77 (65, 92)

75 (64.25, 85.75)

78 (65.50, 95)

0.057

TyG index

9.01 (8.65, 9.41)

8.77 (8.42, 9.06)

9.09 (8.71, 9.52)

 < 0.001

TyG-BMI index

231.59 (210.41, 256.57)

213.89 (195.09, 237.29)

236.59 (213.63, 261.54)

 < 0.001

TG/HDL-C ratio

2.65 (1.83, 3.99)

2.14 (1.53, 2.95)

3.04 (1.89, 4.27)

 < 0.001

METS-IR

41.38 (37.20, 46.38)

38.22 (34.20, 41.91)

42.91 (37.93, 47.55)

 < 0.001

  1. Data are presented as median (interquartile range) or number (proportion, %)
  2. CAD, Coronary artery disease; BMI, body mass index; DM, diabetes mellitus; FPG, fasting plasma glucose; HbA1c, glycated hemoglobin A1c; TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; UA, uric acid; LAD, left atrial diameter; LVDd, left ventricular end diastolic diameter; LVDs, left ventricular systolic diameter; IVS, interventricular septal thickness; LVPW, left posterior wall thickness; LVEF, left ventricular ejection fraction; BNP, B-type natriuretic peptide; CRP, C-reactive protein; Cr, creatinine; TyG index, triglyceride and glucose index; TyG-BMI index, triglyceride glucose-body mass index; TG/HDL-C ratio, triglyceride to high-density lipoprotein cholesterol ratio; METS-IR, metabolic score for insulin resistance